| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Sharangdhar S Phatak | |
| Claudio N Cavasotto | |||
| P433 | issue | 13-14 | |
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 676-683 | |
| P577 | publication date | 2009-05-05 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | Homology modeling in drug discovery: current trends and applications | |
| P478 | volume | 14 |
| Q35685828 | 2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling. |
| Q38084701 | 3D-QSAR and molecular docking for the discovery of ketolide derivatives |
| Q44105963 | A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment. |
| Q40892778 | A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis. |
| Q37280209 | An estimated 5% of new protein structures solved today represent a new Pfam family |
| Q34212790 | Analysis of structure-based virtual screening studies and characterization of identified active compounds |
| Q90001433 | Antinociceptive Action of Moringa peregrina is Mediated by Interaction with α2-Adrenergic Receptor |
| Q34017262 | Beyond the frog: the evolution of homology models of human IKKβ. |
| Q51488490 | Biochemical and in silico Characterization of Recombinant L-Lactate Dehydrogenase of Theileria annulata. |
| Q36009999 | Bioinformatics and variability in drug response: a protein structural perspective |
| Q30388103 | Biological function derived from predicted structures in CASP11. |
| Q42751397 | Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome |
| Q38668657 | Combined HQSAR, topomer CoMFA, homology modeling and docking studies on triazole derivatives as SGLT2 inhibitors |
| Q33805404 | Comparative genomics allowed the identification of drug targets against human fungal pathogens |
| Q52597349 | Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications. |
| Q30398071 | Computational methods in drug discovery. |
| Q47130531 | Computer-Aided Drug Discovery in Plant Pathology |
| Q52654614 | Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design. |
| Q90650682 | Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking |
| Q86169619 | Docking-based three-dimensional quantitative structure-activity relationship (3D-QSAR) predicts binding affinities to aryl hydrocarbon receptor for polychlorinated dibenzodioxins, dibenzofurans, and biphenyls |
| Q42701435 | Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology |
| Q31106005 | Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities |
| Q38194442 | Early state research on antifungal natural products. |
| Q33659530 | EasyModeller: A graphical interface to MODELLER |
| Q38985037 | Effective protein model structure refinement by loop modeling and overall relaxation |
| Q38976083 | Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models. |
| Q38821099 | Exploiting computationally derived out-of-the-box protein conformations for drug design. |
| Q51550199 | Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies. |
| Q47567885 | Finding the needle in the haystack: towards solving the protein-folding problem computationally. |
| Q34153589 | From laptop to benchtop to bedside: structure-based drug design on protein targets. |
| Q56980133 | From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling |
| Q28552650 | GeauxDock: Accelerating Structure-Based Virtual Screening with Heterogeneous Computing |
| Q36409833 | Genome wide analysis of the antimicrobial peptides in Python bivittatus and characterization of cathelicidins with potent antimicrobial activity and low cytotoxicity |
| Q38469746 | Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective |
| Q38088365 | High-throughput and in silico screenings in drug discovery. |
| Q90289365 | Homology Modeling and Docking Study of Shewanella-like Protein Phosphatase Involved in the Development of Ookinetes in Plasmodium |
| Q30424335 | Homology modeling a fast tool for drug discovery: current perspectives |
| Q50868092 | Homology modeling and structural comparison of leucine rich repeats of Toll like receptors 1-10 of ruminants. |
| Q55499257 | HotSpot Wizard 3.0: web server for automated design of mutations and smart libraries based on sequence input information. |
| Q44428752 | Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel |
| Q38823850 | Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors |
| Q28115020 | Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1 |
| Q34092125 | Identification of lead compounds targeting the cathepsin B-like enzyme of Eimeria tenella |
| Q36171916 | Identification of novel Trypanosoma cruzi prolyl oligopeptidase inhibitors by structure-based virtual screening. |
| Q28534433 | Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB |
| Q30399508 | Improving prediction of helix-helix packing in membrane proteins using predicted contact numbers as restraints |
| Q46373691 | In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance |
| Q38968891 | In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics |
| Q64072132 | In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors |
| Q52665081 | In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease. |
| Q33614977 | Inhibition of Eimeria tenella CDK-related kinase 2: From target identification to lead compounds |
| Q35023166 | Integrating prokaryotes and eukaryotes: DNA transposases in light of structure. |
| Q91173661 | Ligand-Induced Conformational Dynamics of A Tyramine Receptor from Sitophilus oryzae |
| Q43686723 | Macromolecular structure and interaction studies of SigF and Usfx in Mycobacterium tuberculosis |
| Q37539924 | Mastering tricyclic ring systems for desirable functional cannabinoid activity |
| Q50967058 | MaxMod: a hidden Markov model based novel interface to MODELLER for improved prediction of protein 3D models. |
| Q38903019 | Modeling of the Binding of Peptide Blockers to Voltage-Gated Potassium Channels: Approaches and Evidence |
| Q30355473 | Modelling three-dimensional protein structures for applications in drug design. |
| Q91657657 | Molecular Architect: A User-Friendly Workflow for Virtual Screening |
| Q36401182 | Molecular Modeling of Myrosinase from Brassica oleracea: A Structural Investigation of Sinigrin Interaction |
| Q49358153 | Molecular and Functional Characterization of pheromone binding protein 1 from the Oriental Fruit Moth, Grapholita molesta (Busck). |
| Q88046085 | Molecular modeling of the AhR structure and interactions can shed light on ligand-dependent activation and transformation mechanisms |
| Q36192601 | Multiple Simulated Annealing-Molecular Dynamics (MSA-MD) for Conformational Space Search of Peptide and Miniprotein |
| Q33553302 | Natural Products as New Treatment Options for Trichomoniasis: A Molecular Docking Investigation |
| Q35686667 | New aryl hydrocarbon receptor homology model targeted to improve docking reliability |
| Q52665485 | New function of TSGA10 gene in angiogenesis and tumor metastasis: a response to a challengeable paradox. |
| Q34956263 | New insights into the binding mode of melanin concentrating hormone receptor-1 antagonists: homology modeling and explicit membrane molecular dynamics simulation study |
| Q39513411 | PL-PatchSurfer2: Improved Local Surface Matching-Based Virtual Screening Method That Is Tolerant to Target and Ligand Structure Variation |
| Q35623545 | PR2ALIGN: a stand-alone software program and a web-server for protein sequence alignment using weighted biochemical properties of amino acids |
| Q47416323 | PREFMD: a web server for protein structure refinement via molecular dynamics simulations |
| Q48368099 | Peptide selectivity between the PDZ domains of human pregnancy-related serine proteases (HtrA1, HtrA2, HtrA3, and HtrA4) can be reshaped by different halogen probes. |
| Q37214412 | Personalized prediction of EGFR mutation-induced drug resistance in lung cancer. |
| Q59350906 | Perspectives towards antiviral drug discovery against Ebola virus |
| Q37626063 | Plasmodium falciparum: new molecular targets with potential for antimalarial drug development |
| Q34669773 | Predicting the accuracy of protein-ligand docking on homology models. |
| Q34321340 | Prediction and identification of T cell epitopes in the H5N1 influenza virus nucleoprotein in chicken |
| Q44646818 | Prediction of the key binding site of odorant-binding protein of Holotrichia oblita Faldermann (Coleoptera: Scarabaeida). |
| Q40551036 | Prediction of the substrate for nonribosomal peptide synthetase (NRPS) adenylation domains by virtual screening |
| Q30415908 | Probing the structure of Leishmania major DHFR TS and structure based virtual screening of peptide library for the identification of anti-leishmanial leads |
| Q57075261 | Protein Homology Modelling |
| Q89920708 | Protein X-ray Crystallography and Drug Discovery |
| Q33994062 | Protein sequence alignment with family-specific amino acid similarity matrices |
| Q30366789 | Protein structure prediction provides comparable performance to crystallographic structures in docking-based virtual screening. |
| Q35540681 | Proteome scale comparative modeling for conserved drug and vaccine targets identification in Corynebacterium pseudotuberculosis |
| Q52567294 | PvaxDB: a comprehensive structural repository of Plasmodium vivax proteome. |
| Q92712521 | RGD-hirudin-based low molecular weight peptide prevents blood coagulation via subcutaneous injection |
| Q35229529 | Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor |
| Q51393729 | Revisiting the homology modeling of G-protein coupled receptors: β1-adrenoceptor as an example. |
| Q38743935 | Role of Structural Bioinformatics in Drug Discovery by Computational SNP Analysis: Analyzing Variation at the Protein Level |
| Q89695592 | SPECS: Integration of side-chain orientation and global distance-based measures for improved evaluation of protein structural models |
| Q28728561 | Software and resources for computational medicinal chemistry |
| Q39417388 | State-of-the-art and dissemination of computational tools for drug-design purposes: a survey among Italian academics and industrial institutions |
| Q90692545 | Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins |
| Q35838161 | Structural determinants of the alpha2 adrenoceptor subtype selectivity |
| Q34968549 | Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas' disease treatment |
| Q36345885 | Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors |
| Q94589436 | Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) |
| Q51061506 | Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery-a structure-based approach. |
| Q30382761 | Template-based protein modeling: recent methodological advances. |
| Q36724064 | The Ascaris suum nicotinic receptor, ACR-16, as a drug target: Four novel negative allosteric modulators from virtual screening. |
| Q37045212 | The GPCR Network: a large-scale collaboration to determine human GPCR structure and function |
| Q31125880 | The histidine-phosphocarrier protein of the phosphoenolpyruvate: sugar phosphotransferase system of Bacillus sphaericus self-associates. |
| Q30416991 | The role of protein structural analysis in the next generation sequencing era. |
| Q34424133 | The talin dimer structure orientation is mechanically regulated |
| Q33893103 | The use of G-protein coupled receptor models in lead optimization |
| Q40760708 | Three amino acid residues of an odorant-binding protein are involved in binding odours in Loxostege sticticalis L. |
| Q30430442 | Unmet challenges of structural genomics |
| Q37946434 | Vibrio cholerae infection, novel drug targets and phage therapy |
| Q36716343 | patGPCR: a multitemplate approach for improving 3D structure prediction of transmembrane helices of G-protein-coupled receptors |
| Q33989429 | ss-TEA: Entropy based identification of receptor specific ligand binding residues from a multiple sequence alignment of class A GPCRs |
Search more.